CEO Update - February 2018
Dear CurAegis Technologies Shareholders,
This is a short update for CurAegis Technologies, Inc. as of February 5, 2018.
CURA System:
We are currently on schedule to have the technology for our MyCadian and other wearable products ready for sales and delivery in late March or early April. Bringing the development management in house seems to be working out very well.
Our pilots are underway despite the existing communication problems with our old system. We continue to develop new potential customers and the need for this technology seems to be more and more evident and in demand. We also have federal agencies eager to do research on the CURA system. We feel that we have some very large and exciting opportunities ahead.
We are starting talks with major wearables companies. These relationships could expand and accelerate our launch and outreach.
CEO Update - December 2017
Dear Shareholders,

The CURA™ Division
As previously reported, we have moved the management and responsibilities for the development of our CURA platform in-house. Our new head of development has taken the last 60 days to analyze what we have and what we have to accomplish to get our technology “product ready”. This has not been an easy task but we have made good strides.
CEO Update - October 2017
Dear Shareholders,
I know it has been a while since my last CEO Report, but we have been waiting for a few events to occur before we could make some important announcements.
CEO Update - May 2017
Dear Shareholders,
CURA™ System

We are on schedule to have our system ready for shipments in the third quarter. As we move closer to our launch, we realize more and more of the incredible potential we have to actually save lives and make people healthier.
CEO Update - January 2017
Dear Shareholders,
We are pleased to announce the appointment of James R. Donnelly as Senior. Vice President of Sales & Marketing for CurAegis™. Mr. Donnelly has extensive experience in wearable technologies as well as start-ups. He is responsible for creating sales and marketing plans, sales processes and supporting the sales vice presidents in each of our identified vertical market opportunities. We are very excited about working with Jim. His abilities and experience match up perfectly to implement and accelerate our sales initiatives.
CEO Update - November 2016
Dear Shareholders,
This is a very interesting time for CurAegis™ which complicates the writing of this report. I have to balance the excitement that we feel and the successes that we have had with the cautious guidance that things don’t always turn out the way one thinks they will. That being said, I will do my best to communicate where we are at this time.

ROCHESTER, N.Y August 11, 2016 (GLOBE NEWSWIRE) On August 11, 2016, Richard A. Kaplan, CEO of CurAegis Technologies, Inc., announced that the company has entered into agreements with six companies to participate in the Beta Trials for our proprietary CURA™ fatigue management system. 

New Ticker Symbol For CurAegis Technologies Inc.
On June 24, 2016, CurAegis Technologies, Inc. (formerly known as Torvec, Inc.) (the “Company”) was notified that the Financial Information Regulatory Association, Inc. has approved the Company’s name change and its request to change the symbol under which its common stock is traded on the OTCQB from “TOVC” to “CRGS.”
Torvec, Inc. Chief Executive Officer Report
Dear Shareholders,
We have had notable accomplishments in the last year.

We have been doing business under the name CurAegis Technologies, a name that reflects our two business divisions...
TORVEC, INC. announces extension of the Series C-3 preferred stock offering through September 1, 2016
ROCHESTER, NEW YORK June 13, 2016 (NEWSWIRE) Richard A. Kaplan, Chief Executive Officer of Torvec, Inc. announced that the Company has extended the offering of the Company’s Series C-3 Voting Convertible Preferred Stock to September 1, 2016. The Company has issued and sold an aggregate of $1,184,500 of the Series C-3 preferred shares to date and the Company’s board of directors has determined that it is in the best interest of the Corporation to further extend this private placement offering.
Z-Coach® 2.0 Aviation Product Launch, CURA Division Beta Programs, CURA Director of Technology Keynote Presentation at SomnoSafe 2016, and Aegis Pump Ready for Third Party Testing at MSOE
ROCHESTER, N.Y., Feb. 11, 2016 (GLOBE NEWSWIRE) -- Richard A. Kaplan, Chief Executive Officer of CurAegis Technologies, a Torvec, Inc. Company (OTCQB:TOVC) is pleased to make the following announcements.

Release of Z-Coach Aviation 2.0
Z-Coach is a robust, interactive fatigue management system developed by leading scientists. Z-Coach provides science based skills, knowledge, tools and practical strategies to enhance sleep, health, alertness, performance and safety.  It is designed to interface with the information from our myCadian watch to provide individualized advice and strategies. Mr. Kaplan states, “Our goal was to create a learning tool that would improve an individual’s quality of life as well as productivity in their workplace.  We believe we are going to save lives and help a lot of people.”

Welcome to the new website (pronounced courageous). We are thrilled to share with you the new vision of our company. Our site is going to be evolving and improving right along with our exciting new products. Product pages will become more in-depth and robust and will provide the latest information.

For more information on our transition to CurAegis Technologies, Inc., please read our most recent Press Release.

Thank you again for your interest and continued support.

Richard A. Kaplan - CEO


ROCHESTER, N.Y., September 17, 2015, (NEWSWIRE) -- Richard A. Kaplan, Chief Executive Officer of Torvec, Inc. (OTCQB – TOVC), Richard A. Kaplan, CEO of Torvec, Inc. announces a name change for the company. He states, “We have split the company into two divisions. The CURA Division will oversee our Fatigue Management Consulting business, and the Aegis Division will oversee our Power and Hydraulic business.”

1999 Mt. Read Blvd. Building 3 | Rochester, NY 14615 | P: 585.254.1100 | F: 585.254.1105
©2018 CurAegis Technologies, Inc. All Rights Reserved. Privacy Policy